ARK Genomic Revolution ETF

ARK·Tracks (actively managed — no index)·Inception Oct 31, 2014

Expense ratio
0.75%
75.0 bps
Net assets
$2.02B
TTM yield
0.00%
Last price
$45.38
as of Sep 10, 2026

Composite score

48/ 100
Cost25

Based on a 0.75% expense ratio.

Liquidity70

Based on $2.02B in net assets.

Concentration30

Top-10 holdings represent 58.8% of net assets.

Tax efficiency78

Thematic base · ETF wrapper · 0.00% TTM yield.

The composite is a weighted average of the four core sub-scores above (cost, tax efficiency, liquidity, concentration). Missing sub-scores fall back to the per-category median when the category has at least 50% data coverage, so funds without (e.g.) parsed N-PORT holdings aren't accidentally boosted by renormalization. Tracking quality is shown where computable but isn't currently part of the composite weighting. Seemethodologyfor formulas, thetracking-qualitypartial-coverage rationale, and the dimensions we deliberatelydon't score(methodology v0.5.1).

Use ARKG in our tools

Top holdings

33 total holdings· as of Apr 30, 2026
#HoldingWeight
1TEMPUS AI INC9.42%
2TWIST BIOSCIENCE CORP8.99%
3CRISPR THERAPEUTICS AG8.91%
410X GENOMICS INC5.77%
5BEAM THERAPEUTICS INC5.43%
6ABSCI CORP4.78%
7NATERA INC4.07%
8ILLUMINA INC4.03%
9INTELLIA THERAPEUTICS INC3.82%
10PERSONALIS INC3.58%

Compare ARKG with another fund

Or skim the closest-overlap funds below.

Similar ETFs by holdings overlap

Open ARKG at a brokerage

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodologyand funding disclosure.

Holdings sourced fromSEC Form N-PORT-P(accession 0000940400-26-025086).